Fibromyalgia as a Disorder of Multi-System Regulation: From Pathogenetic Modeling to Therapeutic Perspectives

Journal title PNEI REVIEW
Author/s Ilaria Demori, Bruno Burlando
Online First 11/18/2026 Issue 2026/Online First
Language English Pages 14 P. 1-14 File size 0 KB
DOI 10.3280/pnei2026oa24255
DOI is like a bar code for intellectual property: to have more infomation click here

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Fibromyalgia (FM) is a multifactorial syndrome characterized by chronic widespread pain and associated symptoms. Despite evidence implicating central nervous system dysfunction and psychoneuroendocrine interactions, its pathogenesis remains unclear, limiting the development of mechanism-based therapies. We discuss FM within the frameworks of Psychoneuroendocrinoimmunology and Dynamical Systems Theory, proposing a pathogenetic model based on interactions between neuroendocrine and thalamocortical regulatory circuits. The model hypothesizes that an imbalance between GABAergic inhibition and glutamatergic excitation, potentially driven by stress and gonadal hormones, may promote a stable state of increased neuronal activity. This framework may help explain the association of FM with stress and its higher prevalence in women. Although not yet experimentally validated, the model is consistent with several literature findings and suggests potential therapeutic targets, including neurosteroids, non-invasive brain stimulation, mind-body therapies and dietary interventions. Overall, this framework may help reconceptualize FM as a disorder of dynamically dysregulated, interconnected systems and guide the development of individualized, mechanism-oriented therapeutic strategies.

  1. Beiner, E., Lucas, V., Reichert, J., Buhai, D. V., Jesinghaus, M., Vock, S., Drusko, A., Baumeister, D., Eich, W., Friederich, H. C., & Tesarz, J. (2023). Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis. Pain, 164(7), 1416–1427.
  2. Blanchini, F., Franco, E., & Giordano, G. (2014). A structural classification of candidate oscillatory and multistationary biochemical systems. Bull Math Biol, 76(10), 2542–2569.
  3. Burlando, B. (2022). A general hypothesis of multistable systems in pathophysiology. F1000Res, 11, 906.
  4. Burlando, B., & Demori, I. (2024). Neurosteroids as a possible new horizon in the treatment of fibromyalgia. Medical Hypotheses, 191.
  5. Chaieb, L., Antal, A., & Paulus, W. (2008). Gender-specific modulation of short-term neuroplasticity in the visual cortex induced by transcranial direct current stimulation. Vis Neurosci, 25(1), 77–81. DOI: 10.1017/S095252380808009
  6. Ciaffi, J., Lisi, L., Mari, A., Mancarella, L., Brusi, V., Pignatti, F., Ricci, S., Vitali, G., Stefanelli, N., Assirelli, E., Neri, S., Naldi, S., Faldini, C., & Ursini, F. (2023). Efficacy, safety and tolerability of very low-calorie ketogenic diet in obese women with fibromyalgia: a pilot interventional study. Front Nutr, 10, 1219321.
  7. Clos-Garcia, M., Andres-Marin, N., Fernandez-Eulate, G., Abecia, L., Lavin, J. L., van Liempd, S.,
  8. Cabrera, D., Royo, F., Valero, A., Errazquin, N., Vega, M. C. G., Govillard, L., Tackett, M. R., Tejada, G., Gonzalez, E., Anguita, J., Bujanda, L., Orcasitas, A. M. C., Aransay, A. M.,…Falcon-Perez, J. M. (2019). Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine, 46, 499–511.
  9. D'Souza, R. S., Klasova, J., Morsi, M., Vincent, A., Mohabbat, A. B., Whitfield, S., Radlicz, C., Sheen, S., Wang, D., Zhitnitsky, M., Saini, C., Al-Hindawi, A., Lopez, K., To, J., Chitneni, A., Graca, M., Gill, B., Her, Y. F., Prokop, L. J., & Hussain, N. (2026). The Prevalence of Fibromyalgia in the General Population and At-Risk Subpopulations: A Systematic Review and Meta-Analysis. Anesth Analg. DOI: 10.1213/ANE.000000000000809
  10. Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019). The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol, 16(8), 461–478.
  11. Demori, I., Giordano, G., Mucci, V., Losacco, S., Marinelli, L., Massobrio, P., Blanchini, F., & Burlando, B. (2022). Thalamocortical bistable switch as a theoretical model of fibromyalgia pathogenesis inferred from a literature survey. J Comput Neurosci, 50(4), 471–484.
  12. Demori, I., Losacco, S., Giordano, G., Mucci, V., Blanchini, F., & Burlando, B. (2024). Fibromyalgia pathogenesis explained by a neuroendocrine multistable model. PLoS One, 19(7), e0303573.
  13. Demori, I., Molinari, E., Rapallo, F., Mucci, V., Marinelli, L., Losacco, S., & Burlando, B. (2022). Online Questionnaire with Fibromyalgia Patients Reveals Correlations among Type of Pain, Psychological Alterations, and Effectiveness of Non-Pharmacological Therapies. Healthcare (Basel), 10(10).
  14. El-Samad, H. (2021). Biological feedback control-Respect the loops. Cell Syst, 12(6), 477–487.
  15. Fernandez-Rodriguez, F. J., Delgado-Perez, E., Salgado-Ortiz, C. S., Quishpe-Rivera, E. A., & Sosa-Reina, M. D. (2026). Inflammatory biomarker alterations in patients with fibromyalgia: a systematic review and meta-analysis. BMC Rheumatol, 10(1).
  16. Fitzgerald, C. T., & Carter, L. P. (2011). Possible role for glutamic acid decarboxylase in fibromyalgia symptoms: a conceptual model for chronic pain. Med Hypotheses, 77(3), 409–415.
  17. Maguire, J. L., & Mennerick, S. (2024). Neurosteroids: mechanistic considerations and clinical prospects. Neuropsychopharmacology, 49(1), 73–82.
  18. Miller, E. E., Jayakrishnan, S., Froio, F., Ahmed, D., Haq, H., Schnurer, S., Messina, M. V., Barillà, B., Saturnino, A., Vomero, M., Marino, A., Navarini, L., Giacomelli, R., Karamagioli, E., Pozzilli, P., & Zoughbie, D. E. (2025). Mediterranean diet and its low-antigenic and anti-inflammatory properties on fibromyalgia: a systematic review. Clinical and Experimental Rheumatology.
  19. Minerbi, A., Gonzalez, E., Brereton, N. J. B., Anjarkouchian, A., Dewar, K., Fitzcharles, M. A., Chevalier, S., & Shir, Y. (2019). Altered microbiome composition in individuals with fibromyalgia. Pain, 160(11), 2589–2602.
  20. Mucci, V., Demori, I., Browne, C. J., Deblieck, C., & Burlando, B. (2023). Fibromyalgia in Pregnancy: Neuro-Endocrine Fluctuations Provide Insight into Pathophysiology and Neuromodulation Treatment. Biomedicines, 11(2).
  21. Ostensen, M., Rugelsjoen, A., & Wigers, S. H. (1997). The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol, 26(5), 355–360. DOI: 10.3109/0300974970906569
  22. Pinto, A. M., Luis, M., Geenen, R., Palavra, F., Lumley, M. A., Ablin, J. N., Amris, K., Branco, J., Buskila, D., Castelhano, J., Castelo-Branco, M., Crofford, L. J., Fitzcharles, M. A., Hauser, W., Kosek, E., Mease, P. J., Marques, T. R., Jacobs, J. W. G., Castilho, P., & da Silva, J. A. P. (2023). Neurophysiological and psychosocial mechanisms of fibromyalgia: A comprehensive review and call for an integrative model. Neurosci Biobehav Rev, 151, 105235.
  23. Proietti, E., Rapallo, F., Molinari, E., Mucci, V., Marinelli, L., Borgarelli, C., Burlando, B., Pisciotta, L., & Demori, I. (2024). Online Questionnaire with Fibromyalgia Patients Shows Negative Correlations between Disease Severity and Adherence to Mediterranean Diet. Nutrients, 16(7).
  24. Qiao, Y. N., Li, L., Hu, S. H., Yang, Y. X., Ma, Z. Z., Huang, L., An, Y. P., Yuan, Y. Y., Lin, Y., Xu, W., Li,
  25. Y., Lin, P. C., Cao, J., Zhao, J. Y., & Zhao, S. M. (2024). Ketogenic diet-produced beta-hydroxybutyric acid accumulates brain GABA and increases GABA/glutamate ratio to inhibit epilepsy. Cell Discov, 10(1), 17.
  26. Salaffi, F., Di Carlo, M., Bazzichi, L., Atzeni, F., Govoni, M., Biasi, G., Di Franco, M., Mozzani, F., Gremese, E., Dagna, L., Batticciotto, A., Fischetti, F., Giacomelli, R., Guiducci, S., Guggino, G., Bentivegna, M., Gerli, R., Salvarani, C., Bajocchi, G.,…Sarzi-Puttini, P. (2021). Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients. Rheumatology (Oxford), 60(2), 728–736.
  27. Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020). Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol, 16(11), 645–660.
  28. Tzadok, R., & Ablin, J. N. (2020). Current and Emerging Pharmacotherapy for Fibromyalgia. Pain Res Manag, 2020, 6541798. DOI: 10.1155/2020/654179
  29. Ustianowska, K., Ustianowski, L., Machaj, F., Goracy, A., Rosik, J., Szostak, B., Szostak, J., & Pawlik,
  30. A. (2022). The Role of the Human Microbiome in the Pathogenesis of Pain. Int J Mol Sci, 23(21).
  31. Vidal-Neira, L. F., Neyro, J. L., Maldonado, G., Messina, O. D., Moreno-Alvarez, M., & Rios, C. (2024). Climacteric and fibromyalgia: a review. Climacteric, 27(5), 458–465. DOI: 10.1080/13697137.2024.237619
  32. Wise, P. M. (2002). Estrogens and neuroprotection. Trends Endocrinol Metab, 13(6), 229–230.
  33. Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Hauser, W., Katz, R. L., Mease, P. J., Russell, A. S., Russell, I. J., & Walitt, B. (2016). 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum, 46(3), 319–329.
  34. Wu, E., Brener, A., Hiser, J. K. D., Hill, D. L. K., & Farmer, J. O. (2025). Fibromyalgia: Update on pathogenesis and management. European Journal of Rheumatology, 12(4), e25032.
  35. Demori, I., & Burlando, B. (2026). Fibromyalgia as a Disorder of Multi-System Regulation: From Pathogenetic Modeling to Therapeutic Perspectives. PNEI Review - Open Access. https://doi.org/10.3280/pnei2026oa24255
  36. Foerster, B. R., Petrou, M., Edden, R. A., Sundgren, P. C., Schmidt-Wilcke, T., Lowe, S. E., Harte, S. E., Clauw, D. J., & Harris, R. E. (2012). Reduced insular gamma-aminobutyric acid in fibromyalgia. Arthritis Rheum, 64(2), 579–583.
  37. Freyer, F., Roberts, J. A., Ritter, P., & Breakspear, M. (2012). A canonical model of multistability and scale-invariance in biological systems. PLoS Comput Biol, 8(8), e1002634.
  38. Genc, H., Atasever, M., Duyur Cakit, B., Seval, M., & Koc, A. (2017). The Effects of Fibromyalgia Syndrome on Physical Function and Psychological Status of Pregnant Females. Arch Rheumatol, 32(2), 129–140.
  39. Groh, A., Krieger, P., Mease, R. A., & Henderson, L. (2018). Acute and Chronic Pain Processing in the Thalamocortical System of Humans and Animal Models. Neuroscience, 387, 58–71.
  40. Iannuccelli, C., Favretti, M., Bianchi, B., Dolcini, G., Cauli, C., Ferraro, V., Gioia, C., Bazzichi, L., Atzeni, F., Batticciotto, A., Galli, F., Varrassi, G., Ablin, J. N., Gualtierotti, R., Conti, F., Di Franco, M., Salaffi, F., Sarzi-Puttini, P., Di Carlo, M., & Pain Study Group of the Italian Society of, R. (2026). Pathogenetic and clinical aspects of fibromyalgia: one year in review 2026. Clin Exp Rheumatol, 44(6), 1057–1068.
  41. Iannuccelli, C., Favretti, M., Dolcini, G., Di Carlo, M., Pellegrino, G., Bazzichi, L., Atzeni, F., Lucini, D., Varassi, G., Leoni, M. L. G., Fornasari, D. M. M., Conti, F., Salaffi, F., Sarzi-Puttini, P., & Di Franco, M. (2025). Fibromyalgia: one year in review 2025. Clin Exp Rheumatol, 43(6), 957–969.
  42. Jaeger, J., & Monk, N. (2014). Bioattractors: dynamical systems theory and the evolution of regulatory processes. J Physiol, 592(11), 2267–2281.
  43. Jurado-Priego, L. N., Cueto-Urena, C., Ramirez-Exposito, M. J., & Martinez-Martos, J. M. (2024). Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies. Biomedicines, 12(7).
  44. Kerrebijn, I., Bjornsdottir, G., Arbabi, K., Urpa, L., Haapaniemi, H., Thorleifsson, G., Stefansdottir, L., Frangakis, S., Valliere, J., Kunorozva, L., Abner, E., Ji, C., Kangur, M., Aagaard, B., Bliddal, H., Brunak, S., Bruun, M. T., Didriksen, M., Erikstrup, C.,…Wainberg, M. (2026). The genetic architecture of fibromyalgia across 2.5 million individuals. Nat Med, 32(8), 3060–3070.
  45. Kosek, E. (2024). The concept of nociplastic pain-where to from here? Pain, 165(11S), S50–S57.
  46. Kulekcioglu, S. (2022). Diagnostic difficulty, delayed diagnosis, and increased tendencies of surgical treatment in fibromyalgia syndrome. Clin Rheumatol, 41(3), 831–837.
  47. Lam, Y. W., & Sherman, S. M. (2011). Functional organization of the thalamic input to the thalamic reticular nucleus. J Neurosci, 31(18), 6791–6799. DOI: 10.1523/JNEUROSCI.3073-10.201
  48. Laurin, A., Nard, N., Dalmont, M., Bulteau, S., Benard, C., Bonnot, O., Winer, N., Dupont, F., Apter, G., Terranova-Commessie, F., Guillin, O., El-Hage, W., Sauvaget, A., & Rotharmel, M. (2022). Efficacy and Safety of Transcranial Electric Stimulation during the Perinatal Period: A Systematic Literature Review and Three Case Reports. J Clin Med, 11(14).
  49. Liu, Y. Z., Wang, Y. X., & Jiang, C. L. (2017). Inflammation: The Common Pathway of Stress-Related Diseases. Front Hum Neurosci, 11, 316.
  50. Macfarlane, G. J., Kronisch, C., Dean, L. E., Atzeni, F., Hauser, W., Fluss, E., Choy, E., Kosek, E., Amris, K., Branco, J., Dincer, F., Leino-Arjas, P., Longley, K., McCarthy, G. M., Makri, S., Perrot, S., Sarzi-Puttini, P., Taylor, A., & Jones, G. T. (2017). EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis, 76(2), 318–328.
  51. Ahmed, I., Mustafaoglu, R., Memon, A. R., Zafeer, R., Xiong, H., Straudi, S., & Runge, N. (2025). Comparative Effectiveness of Noninvasive Brain Stimulation for the Treatment of Pain, Fatigue, and Sleep Quality in Fibromyalgia. A Systematic Review With Network Meta-Analysis. Clin J Pain, 41(5). DOI: 10.1097/AJP.000000000000128
  52. Aloisi, A. M., & Sorda, G. (2011). Relationship of female sex hormones with pain perception: focus on estrogens. Pain Manag, 1(3), 229–238.
  53. Alonso, C., Loevinger, B. L., Muller, D., & Coe, C. L. (2004). Menstrual cycle influences on pain and emotion in women with fibromyalgia. J Psychosom Res, 57(5), 451–458.
  54. Angeline, S., Tiyatiye, B., & Akosile, W. (2025). Transcranial Magnetic Stimulation in Pregnancy: Efficacy, Safety, and Future Implications for Perinatal Mental Health Care. Brain Behav, 15(2), e70304.
  55. Arout, C. A., Sofuoglu, M., Bastian, L. A., & Rosenheck, R. A. (2018). Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study. J Womens Health (Larchmt), 27(8), 1035–1044.
  56. Beiner, E., Hermes, M., Reichert, J., Kleinke, K., Vock, S., Loffler, A., Ader, L., Sirazitdinov, A., Keil, S., Schmidt, T., Schick, A., Loffler, M., Hopp, M., Ruckes, C., Hesser, J., Reininghaus, U., Flor, H., Eich, W., & Tesarz, J. (2025). Early-life adversity as a predictor of fibromyalgia syndrome: the central role of perceived stress over endocrine stress indicators. Pain, 166(8), 1871–1881.

Ilaria Demori, Bruno Burlando, Fibromyalgia as a Disorder of Multi-System Regulation: From Pathogenetic Modeling to Therapeutic Perspectives in "PNEI REVIEW" Online First/2026, pp 1-14, DOI: 10.3280/pnei2026oa24255